endacea is a development stage biopharmaceutical company with a proprietary a1 adenosine receptor based technology platform for the treatment of asthma, ischemia-reperfusion organ injury, and gram-negative septicemia (endotoxemia), as well as an assay for endotoxin.
copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)